Access Advocate for Clinical Research Participation

About this funding opportunity

Animations

Home Page

Save for later

Access Advocate for Clinical Research Participation

Donate Now

Funding Opportunities Save for later Access Advocate for Clinical Research Participation

Objective:

This program will support implementation and evaluation of a Parkinson’s disease (PD) focused Access Advocate model designed to increase inclusive research participation. Funding will support Access Advocates at clinical sites to build practical, relationship based pathways to improving representative research enrollment and retention.

MJFF will prioritize proposals that: Demonstrate strong PD study volume, including interventional clinical trials, and readiness to support study referrals. Establish well defined Access Advocate role with appropriate training and supervision. Implement repeatable workflows for identifying potential participants, assessing barriers, connecting people to resources and follow-up. Include a feasible plan to track recruitment, retention, and barrier related metrics and site-relevant health system outcomes. Show Access Advocates' effect on recruiting and retaining underrepresented groups in PD studies. Commit to participating in cross-site learnings to share insights and improve the Access Advocate model.

Download the program overview for a detailed list of proposal evaluation criteria.

MJFF will NOT consider proposals from sites: Outside of the US and Canada. Without active or planned interventional PD clinical trials. Proposing a model centered primarily on broad community outreach rather than clinic and trial connected access advocacy.

Important notice:MJFF will be conducting two Q&A sessions to answer any questions related to the RFA on: Monday, May 11 at 1:00 p.m. US ET Friday, May 15 at 2:00 p.m. US ET

To attend an information session, please sign uphere.

Please note that MJFF has an Open Science Policy which governs research outputs (such as preprints, journal articles, data, code, and software) resulting from MJFF-funded work. The Open Science Policy applies to this funding program and includes specific rules, timing, and format for the return of those research outputs and requires them to be shared openly, to be free to access, and with persistent identifiers. Please contact openscience@michaeljfox.org for questions about the Open Science Policy.

We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.

I Understand

a17495660521.cdn.optimizely.com a17495660521.cdn.optimizely.com is blocked

This page has been blocked by an extension Try disabling your extensions.

ERR_BLOCKED_BY_CLIENT

Reload

This page has been blocked by an extension

Topic areas: Life Sciences and Health, Social Innovation and Community Development, Education and Training.

Funding amount

This grant provides Varies in funding.

Deadline

Applications are accepted on a rolling basis; there is no single fixed deadline.

Who can apply

This opportunity is open to the following applicant types:

• Not specified by the program.

Eligibility

The program did not publish a separate eligibility statement. See the official opportunity page for the full eligibility criteria.

Agency

Access Advocate for Clinical Research Participation is administered by Michael J. Fox Foundation (MJFF), listed via Michael J. Fox Foundation.